Vol 10, Supplement 17 (June 20, 2018): Journal of Thoracic Disease

Editorial

Lung cancer surgery for octogenarians: an option for select patients only?

Jun Nakajima

PDF Pages: S1920-S1922 Full Text (1329) Open Access

The new era of whole-exome sequencing in congenital heart disease: brand-new insights into rare pathogenic variants

Ares Pasipoularides

PDF Pages: S1923-S1929 Full Text (2373) Open Access

Pulmonary metastasectomy and laser-assisted resection

Nikolaos Panagiotopoulos, Davide Patrini, David Lawrence, Marco Scarci, Sofoklis Mitsos

PDF Pages: S1930-S1933 Full Text (2300) Open Access

The burden of heart failure in the general population: a clearer and more concerning picture

Thomas G. von Lueder, Stefan Agewall

PDF Pages: S1934-S1937 Full Text (2487) Open Access

Are predictive models useful in clinical medicine?

Robert J. Cerfolio

PDF Pages: S1938-S1939 Full Text (1479) Open Access

Cetuximab in the treatment of advanced non-small cell lung cancer: FISHing for a miraculous catch

Lorenza Landi, Antonio Rossi

PDF Pages: S1940-S1944 Full Text (1221) Open Access

Efficacy and immune activation of ipilimumab in early-stage lung cancer patients

Shingo Noguchi, Kazuhiro Yatera

PDF Pages: S1945-S1948 Full Text (1470) Open Access

Transcatheter Mitral Valve Replacement: slow and steady progress

David W. M. Muller

PDF Pages: S1949-S1952 Full Text (1678) Open Access

The more and the heavier may not always be an answer

Hongryull Pyo, Se-Hoon Lee, Jhingook Kim

PDF Pages: S1953-S1955 Full Text (1532) Open Access

Mesothelioma diagnosis and prognosis, are we moving beyond histology and performance status towards circulating biomarkers?

Oluf Dimitri Røe

PDF Pages: S1956-S1961 Full Text (4904) Open Access

Hydrocortisone in septic shock: all the questions answered?

Josef Briegel, Volker Huge, Patrick Möhnle

PDF Pages: S1962-S1965 Full Text (14316) Open Access

Malignant pleural mesothelioma: main topics of American Society of Clinical Oncology clinical practice guidelines for diagnosis and treatment

Malgorzata Szolkowska, Katarzyna Blasinska-Przerwa, Magdalena Knetki-Wroblewska, Piotr Rudzinski, Renata Langfort

PDF Pages: S1966-S1970 Full Text (1531) Open Access

The optimal sequencing of postoperative chemotherapy and radiation therapy in patients with locally advanced or incompletely resected non-small cell lung cancer

Michael J. Weyant

PDF Pages: S1971-S1973 Full Text (1131) Open Access

Comparing apples to oranges: short-term mortality after surgery versus stereotactic body radiotherapy for early-stage non-small cell lung cancer

Kathryn E. Engelhardt, David D. Odell, Malcolm M. DeCamp

PDF Pages: S1974-S1976 Full Text (1157) Open Access

Application of bronchoscope for the placement of nasoenteric feeding tube: new ideas from old ways

Ching Feng Wu, Yin-Kai Chao

PDF Pages: S1977-S1978 Full Text (1304) Open Access

Patient selection for VV ECMO: have we found the crystal ball?

Abhilasha Ahuja, Kiran Shekar

PDF Pages: S1979-S1981 Full Text (2586) Open Access

Targeting minimal residual disease after surgery with molecular targeted therapy: the real path to a cure?

Katsuhiro Masago, Shiro Fujita, Yasushi Yatabe

PDF Pages: S1982-S1985 Full Text (2525) Open Access

Can molecularly targeted therapy cure patients with resected EGFR mutant NSCLC?

Myron Klevansky, Thomas John

PDF Pages: S1986-S1988 Full Text (1841) Open Access

EML4-ALK V3, treatment resistance, and survival: refining the diagnosis of ALK⁺ NSCLC

Petros Christopoulos, Martina Kirchner, Volker Endris, Albrecht Stenzinger, Michael Thomas

PDF Pages: S1989-S1991 Full Text (3091) Open Access

Elective ICU admission after major surgery: can too much support be futile?

Fernando G. Zampieri

PDF Pages: S1992-S1994 Full Text (1646) Open Access

Lung cancer resection in octogenarian patients

Lorenzo Spaggiari, Francesco Petrella, Paolo Maione, Cesare Gridelli

PDF Pages: S1995-S1997 Full Text (1326) Open Access

Minimally invasive surgery is best treatment for early lung cancer

Scott J. Swanson

PDF Pages: S1998-S1999 Full Text (1028) Open Access

Stereotactic body radiotherapy for operable, early stage non-small cell lung cancer—let’s all take a deep breath

Eric B. Howell, Kathleen S. Berfield, Douglas E. Wood

PDF Pages: S2000-S2003 Full Text (1391) Open Access

Stereotactic body radiotherapy for early-stage non-small cell lung cancer has low post-treatment mortality

Joshua R. Niska, Terence T. Sio, Thomas B. Daniels, Staci E. Beamer, Dawn E. Jaroszewski, Helen J. Ross, Harshita R. Paripati, Steven E. Schild

PDF Pages: S2004-S2006 Full Text (1741) Open Access

Surgery vs. SBRT in retrospective analyses: confounding by operability is the elephant in the room

William A. Stokes, Chad G. Rusthoven

PDF Pages: S2007-S2010 Full Text (3342) Open Access

The immune system as a victim and aggressor in chronic obstructive pulmonary disease

Joshua J. C. McGrath, Martin R. Stampfli

PDF Pages: S2011-S2017 Full Text (2171) Open Access

Strategy of intentional limited resection for lung adenocarcinoma in situ

Terumoto Koike, Teruaki Koike, Masaya Nakamura, Yuki Shimizu, Tatsuya Goto, Seijiro Sato, Masanori Tsuchida

PDF Pages: S2018-S2021 Full Text (1519) Open Access

Weighing the relative importance of short-term versus long-term outcomes when comparing surgery versus stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer

Paul J. Speicher, Thomas A. D’Amico

PDF Pages: S2022-S2024 Full Text (1441) Open Access

Developing competency in video-assisted thoracic surgery (VATS) lobectomy

Lars Konge, René Horsleben Petersen, Charlotte Ringsted

PDF Pages: S2025-S2028 Full Text (1544) Open Access

Reperfusion injury to ischemic medullary brain nuclei after stopping continuous positive airway pressure-induced CO₂-reduced vasoconstriction in sleep apnea

J. Howard Jaster

PDF Pages: S2029-S2031 Full Text (1154) Open Access

SECURE PCI: how important can a subgroup analysis be?

Mathieu Kerneis, Megan K. Yee, C. Michael Gibson

PDF Pages: S2032-S2034 Full Text (1794) Open Access

In acute respiratory distress syndrome, is extracorporeal membrane oxygenation an adjuvant for “everyone”?

Lars Mikael Broman

PDF Pages: S2035-S2039 Full Text (1332) Open Access

The PRESET-Score: the extrapulmonary predictive survival model for extracorporeal membrane oxygenation in severe acute respiratory distress syndrome

Santiago Montero, Arthur S. Slutsky, Matthieu Schmidt

PDF Pages: S2040-S2044 Full Text (2689) Open Access

Infection and colonisation in V-V ECMO—not a predictor of poor outcome

Christoph Fisser, Maximilian Valentin Malfertheiner

PDF Pages: S2045-S2047 Full Text (2216) Open Access

Editorial based on: “Risk of dementia in adults with congenital heart disease: population-based cohort study”

Mirthe J. Mebius, Marcus T. R. Roofthooft, Arend F. Bos

PDF Pages: S2048-S2051 Full Text (1298) Open Access

Between hypoxia or hyperoxia: not perfect but more physiologic

Chiara Robba, Lorenzo Ball, Paolo Pelosi

PDF Pages: S2052-S2054 Full Text (2369) Open Access

Who benefits from postoperative ICU admissions?—more research is needed

Chi-Min Park, Gee Young Suh

PDF Pages: S2055-S2056 Full Text (3702) Open Access

What about prognostic outcome parameters in patients with acute respiratory distress syndrome (ARDS) treated with veno-venous extracorporeal membrane oxygenation (VV-ECMO)?

Thomas Datzmann, Karl Träger

PDF Pages: S2057-S2061 Full Text (2732) Open Access

Early treatment with high-potency statins in patients with acute coronary syndrome—an example of personalized medicine

Emanuel Harari, Alon Eisen

PDF Pages: S2062-S2066 Full Text (4551) Open Access

Fat but fit for the improved survival in lung cancer surgery

Luca Bertolaccini, Francesca Calabrese, Jury Brandolini, Barbara Bonfanti, Sergio Nicola Forti Parri, Nicola Lacava, Piergiorgio Solli

PDF Pages: S2067-S2069 Full Text (1102) Open Access

Early oral intake through meticulous chewing after esophagectomy

Ian Wong, Simon Law

PDF Pages: S2070-S2073 Full Text (1108) Open Access

Who really benefits from surgical tray reduction?

Ava John-Baptiste

PDF Pages: S2074-S2075 Full Text (2101) Open Access

MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway

Ramon Andrade De Mello, Pedro Nazareth Aguiar, Hakaru Tadokoro, Tállita Meciany Farias-Vieira, Pedro Castelo-Branco, Gilberto de Lima Lopes, Daniel Humberto Pozza

PDF Pages: S2076-S2078 Full Text (1805) Open Access

Prone Positioning for ARDS: still misunderstood and misused

Francesco Pugliese, Cristina Babetto, Francesco Alessandri, Vito Marco Ranieri

PDF Pages: S2079-S2082 Full Text (4112) Open Access

Letter to the Editor

Invited letter to the editor on the editorial on “Clinical staging of NSCLC: current evidence and implications for adjuvant chemotherapy”

David Jonathan Heineman, Johannes Marlene Daniels, Wilhelmina Hendrika Schreurs

PDF Pages: S2083-S2085 Full Text (1080) Open Access

Need for prospective collection of experience and repeated samples in esophageal squamous cell carcinoma

Yasuo Hamamoto

PDF Pages: S2086-S2088 Full Text (1276) Open Access

Using the scoring schemes in the right way: the dynamic assessment of stroke and bleeding risk in patients with atrial fibrillation

Tze-Fan Chao, Shih-Ann Chen

PDF Pages: S2089-S2091 Full Text (1612) Open Access

Prone positioning acute respiratory distress syndrome patients

Claude Guérin

PDF Pages: S2092-S2094 Full Text (2110) Open Access

Primary malignant melanoma of esophagus shared similar genetic characters with both cutaneous and oral mucosal melanoma

Jingjing Li, Shi Yan, Nan Wu

PDF Pages: S2095-S2096 Full Text (1215) Open Access

Adjuvant therapy for resected pN2 non-small cell lung cancer: sequence is not all that matters

Kristine E. Kokeny, Samual Francis, Randa Tao, Ying J. Hitchcock

PDF Pages: S2097-S2099 Full Text (959) Open Access

Pulmonary nodules measurements in CT lung cancer screening

Marjolein A. Heuvelmans, Matthijs Oudkerk

PDF Pages: S2100-S2102 Full Text (1901) Open Access

Disclosure:

The supplement was commissioned by the Editorial office, Journal of Thoracic Disease without any sponsorship or funding.